GOLDMAN SACHS GROUP INC - PDS BIOTECHNOLOGY CORP ownership

PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 80 filers reported holding PDS BIOTECHNOLOGY CORP in Q2 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of PDS BIOTECHNOLOGY CORP
ValueSharesWeighting
Q3 2023$67,276
-51.7%
13,322
-51.9%
0.00%
Q2 2023$139,321
-73.4%
27,698
-67.5%
0.00%
Q1 2023$523,802
+184.7%
85,171
+186.3%
0.00%
Q1 2022$184,000
-28.4%
29,752
-6.3%
0.00%
Q4 2021$257,000
+51.2%
31,762
+178.7%
0.00%
Q3 2021$170,000
+78.9%
11,395
-45.4%
0.00%
Q1 2021$95,000
+126.2%
20,867
+6.5%
0.00%
Q4 2020$42,00019,6000.00%
Other shareholders
PDS BIOTECHNOLOGY CORP shareholders Q2 2023
NameSharesValueWeighting ↓
INSPIRION WEALTH ADVISORS, LLC 314,119$933,0000.21%
New Leaf Venture Partners, L.L.C. 117,242$348,0000.21%
Iron Gate Global Advisors LLC 75,016$223,0000.06%
ACT CAPITAL MANAGEMENT, LLC 12,000$36,0000.05%
KNIGHTSBRIDGE ASSET MANAGEMENT, LLC 43,916$130,0000.03%
Andesa Financial Management Inc. 25,000$74,0000.03%
Sofinnova Investments, Inc. 142,635$424,0000.02%
Ellis Investment Partners, LLC 6,850$20,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 22,496$67,0000.01%
Valeo Financial Advisors, LLC 21,570$64,0000.00%
View complete list of PDS BIOTECHNOLOGY CORP shareholders